New implantation device for intractable epilepsy
RNS for Epilepsy Has Long-Term Benefits More than half of epilepsy patients treated with the recently approved responsive neurostimulation device (RNS) had reductions of 50% from baseline in seizure frequency lasting for up to 80 months, researchers reported here. Among 250 participants in the pivotal trial of the implanted RNS System neurostimulator, approved last month…